WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+4.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.82B
AUM Growth
+$779M
(+13%)
Cap. Flow
+$725M
Cap. Flow
% of AUM
10.62%
Top 10 Holdings %
Top 10 Hldgs %
15.75%
Holding
877
New
205
Increased
123
Reduced
98
Closed
183
Top Buys
| 1 |
Qorvo
QRVO
|
$151M |
| 2 |
ASML
ASML
|
$118M |
| 3 |
Revolution Medicines
RVMD
|
$51.9M |
| 4 |
Intuitive Surgical
ISRG
|
$50.7M |
| 5 |
Meta Platforms (Facebook)
META
|
$50.2M |
Top Sells
| 1 |
Teradyne
TER
|
$132M |
| 2 |
Qualcomm
QCOM
|
$77.3M |
| 3 |
KLA
KLAC
|
$70.4M |
| 4 |
Abbott
ABT
|
$69.2M |
| 5 |
Booking.com
BKNG
|
$67.7M |
Sector Composition
| 1 | Healthcare | 42.14% |
| 2 | Technology | 30.14% |
| 3 | Communication Services | 6.89% |
| 4 | Industrials | 6.58% |
| 5 | Financials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBT
151
DELISTED
Welbilt, Inc.
WBT
| $13M | 0.19% |
548,701
+150,378
| +38% | +$3.57M |
|
152
Canadian Pacific Kansas City
CP
$70.3B
| $13M | 0.19% |
+180,682
| New | +$13M |
|
153
Vor Biopharma
VOR
$248M
| $12.9M | 0.18% |
1,111,123
| – | – |
|
154
Roper Technologies
ROP
$55.8B
| $12.7M | 0.18% |
+25,846
| New | +$12.7M |
|
155
Humana
HUM
$37B
| $12.7M | 0.18% |
+27,309
| New | +$12.7M |
|
156
Ingersoll Rand
IR
$32.2B
| $12.6M | 0.18% |
+204,112
| New | +$12.6M |
|
157
AutoZone
AZO
$70.6B
| $12.6M | 0.18% |
+6,000
| New | +$12.6M |
|
158
Ionis Pharmaceuticals
IONS
$9.76B
| $12.5M | 0.18% |
411,454
+5,993
| +1% | +$182K |
|
159
Passage Bio
PASG
$22.8M
| $12.2M | 0.17% |
95,751
+79,661
| +495% | +$10.1M |
|
160
Lowe's Companies
LOW
$151B
| $12.1M | 0.17% |
+47,000
| New | +$12.1M |
|
161
Thermo Fisher Scientific
TMO
$186B
| $12M | 0.17% |
+17,953
| New | +$12M |
|
|
IGMS
162
DELISTED
IGM Biosciences
IGMS
| $11.8M | 0.17% |
403,401
-165,608
| -29% | -$4.86M |
|
163
Iovance Biotherapeutics
IOVA
$901M
| $11.8M | 0.17% |
618,703
+433,151
| +233% | +$8.27M |
|
164
Playtika
PLTK
$1.4B
| $11.8M | 0.17% |
682,172
-404,819
| -37% | -$7M |
|
165
IDEAYA Biosciences
IDYA
$2.38B
| $11.8M | 0.17% |
498,187
+353,808
| +245% | +$8.36M |
|
166
Silicon Laboratories
SLAB
$4.45B
| $11.8M | 0.17% |
57,046
-153,338
| -73% | -$31.7M |
|
167
Fate Therapeutics
FATE
$116M
| $11.6M | 0.17% |
199,076
+46,119
| +30% | +$2.7M |
|
|
STKL
168
SunOpta
STKL
$779M
| $11.6M | 0.17% |
1,672,273
-1,200,841
| -42% | -$8.35M |
|
169
PepsiCo
PEP
$200B
| $11.6M | 0.17% |
+66,800
| New | +$11.6M |
|
170
Pulmonx
LUNG
$70.9M
| $11.6M | 0.17% |
361,607
+25,294
| +8% | +$811K |
|
171
TriNet
TNET
$3.43B
| $11.6M | 0.17% |
121,524
+38,867
| +47% | +$3.7M |
|
172
HCA Healthcare
HCA
$98.5B
| $11.5M | 0.16% |
44,687
-66,132
| -60% | -$17M |
|
173
Stryker
SYK
$150B
| $11.5M | 0.16% |
42,908
+5,082
| +13% | +$1.36M |
|
|
VG
174
DELISTED
Vonage Holdings Corporation
VG
| $11.4M | 0.16% |
+548,700
| New | +$11.4M |
|
|
JNCE
175
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $11.4M | 0.16% |
+1,359,528
| New | +$11.4M |
|